Trinity Biotech Announces Q3 2021 Results, the Entry Into a $81,250,000 Loan Facility to Refinance the Company’s Exchangeable Senior Notes and Agreements To Repurchase Outstanding Exchangeable Senior Notes

NEXT STORY
FDA’s OTAT in Agreement With 12-Month Reduction in Pain as Primary Endpoint for Chronic Low Back Pain Program
PREV STORY
Immix Biopharma, Inc. Announces Pricing of Initial Public Offering
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

DIAGNOS announces a 3-year partnership agreement with the University of Montreal Hospital Centre (CHUM) on the use of Artificial Intelligence

author_avatar
NASDAQ Market News

Roche to present new and updated data at ESMO 2019 reinforcing the use of Alecensa in the first-line setting for advanced ALK-positive non-small cell lung cancer

author_avatar
NASDAQ Market News

Change in the Number of Shares and Votes in Immunicum

Press Release 31 January 2018 Change in the Number of Shares and Votes in ...

author_avatar
NASDAQ Market News